Home / Inspections / 1077858

FDA Inspection 1077858 — Adare Pharmaceuticals, Inc.

Adare Pharmaceuticals, Inc. — FEI 1525864

The FDA completed an inspection of Adare Pharmaceuticals, Inc. on January 25, 2019 in Vandalia, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vandalia, OH (United States)

Facility

Other inspections at this facility

  • 1261982 (VAI Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1063146 (NAI Wed Jul 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1014959 (NAI Fri May 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904602 (VAI Fri Nov 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 809244 (NAI Fri Nov 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources